CARLSBAD, Calif., Jan. 6 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), the leader in antisense therapeutics, today...
CARLSBAD, Calif., Jan. 5 /PRNewswire/ -- Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials...
OGX-011 Phase 3 Studies in First- and Second-Line Advanced Prostate Cancer and Non-Small Cell Lung Cancer Expected to Begin in 2010 and Early 2011...
CARLSBAD, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Dear Isis Supporters and Shareholders, I would like to start by thanking you for your...
CARLSBAD, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), the leader in antisense therapeutics, today...
CARLSBAD, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), the leader in antisense therapeutics, today...
Isis Pharmaceuticals Inc.'s (ISIS) second-quarter loss narrowed, helped by revenue generated by its partnership with Genzyme Corp. (GENZ), as the...
- Conference Call Webcast Thursday, August 6, 08:30 a.m. EDT at www.isispharm.com CARLSBAD, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Isis...
CARLSBAD, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), the leader in antisense therapeutics, today...
Genzyme Corp. (GENZ) and Isis Pharmaceuticals Inc. (ISIS) reported the success of a late-stage trial of cholesterol treatment mipomersen, but Wall...
Genzyme Corp. (GENZ) and Isis Pharmaceuticals Inc. (ISIS) said its mipomersen drug cut so-called bad cholesterol levels by 25% in a late-stage...
Isis Pharmaceuticals Inc. (ISIS) swung to a first-quarter profit as revenue generated by its partnership with Genzyme Corp. (GENZ) and a gain from...
VANCOUVER, Feb. 14 /PRNewswire-FirstCall/ -- OncoGenex Technologies Inc., announced the appointment of Mr. Stephen Anderson as Chief Financial...
VANCOUVER, Aug. 16 /PRNewswire-FirstCall/ -- OncoGenex Technologies Inc., a clinical-stage biotechnology company developing targeted...
RNS Number:9054D ISIS Asset Management PLC 08 October 2004 To: London Stock Exchange Attention: RNS Date: 8 October 2004 From: ISIS...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.